NCT05794477 2023-06-02
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2 Unknown
Shanghai Hengrui Pharmaceutical Co., Ltd.
Huabo Biopharm Co., Ltd.
Shanghai Pulmonary Hospital, Shanghai, China
Samsung Medical Center
Samsung Medical Center
SuZhou Stainwei Biotech Inc.
The Korean Society of Pediatric Hematology Oncology
Sun Yat-sen University
Sun Yat-sen University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Southern Europe New Drug Organization